Pythia Biosciences
- Company typePrivate
- Founded2023
- HeadquartersCarlsbad, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Pythia Biosciences firmographics
Firmographics- Name
- Pythia Biosciences
- Legal name
- Pythia Biosciences
- Website
- https://pythiabio.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Where Pythia Biosciences is headquartered
LocationHeadquarters
- HQ city
- Carlsbad
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Pythia Biosciences business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- C-DIAM Multi-Omics Studio SaaS Platform Subscription: Web-based SaaS platform for multi-omics data analysis and integration. The platform is accessed via subscription, with enterprise and academic pricing tiers. Regional channel partners distribute the platform in international markets.
- Single-Cell Curation and Atlas Building Services: End-to-end data curation services including deep search of relevant single-cell datasets, quality control, preprocessing, metadata harmonization, ontology mapping, atlas building, and data engineering. Services are tailored to customer therapeutic areas of interest and delivered via standardized SOPs.
Go-to-market motion2 records
Distribution channels6 records
Marketing channels7 records
Pythia Biosciences product offering
Product offeringCore offering
Pythia Biosciences provides the C-DIAM Multi-Omics Studio, a cloud-based SaaS platform that enables biologists and bioinformaticians to analyze and integrate multi-omics data including single-cell RNA-seq, spatial transcriptomics (10x Visium HD, Visium, Stereo-seq, Xenium, CosMx), proteomics, metabolomics, and bulk RNA-seq through a no-code graphical user interface. The platform is complemented by the Pythiomics curated single-cell database (~126 million cells with AI-driven metadata harmonization), Pythiomics APIs for programmatic access, and Single-Cell Curation and Atlas Building Services for end-to-end dataset delivery.
Product overview
Pythia Biosciences offers a unified product ecosystem centered on the C-DIAM Multi-Omics Studio platform—a cloud-based SaaS analytics platform for multi-omics data analysis and integration. The platform integrates with the Pythiomics Database (a curated single-cell database of ~126 million cells accessible via web interface and APIs) and is complemented by Single-Cell Curation and Atlas Building Services. The product portfolio enables researchers to analyze single-cell RNA-seq, spatial transcriptomics, proteomics, metabolomics, and bulk RNA-seq data through an intuitive GUI, with capabilities spanning cell type annotation, differential expression analysis, pathway enrichment, target and biomarker discovery workflows, and multi-omics cross-validation. The company also provides educational resources including ebooks and webinars. Regional distribution partnerships (Japan, India, South Korea) extend platform availability through local implementation partners.
Differentiator
Problem solved
Functional benefit
Brands
- C-DIAM Multi-Omics Studio: Web-based platform for multi-omics data analysis and integration supporting single-cell RNA-seq, spatial transcriptomics, proteomics, and metabolomics.
- Pythiomics
Products and services
- C-DIAM Multi-Omics Studio
Quantifiable outcome
- The Pythiomics database enables pharma customers to save extensive time and cost of data finding, cleaning, processing, and harmonizing.
- +1 more outcomes
Companies that use Pythia Biosciences
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Pythia Biosciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability6 records
Feature12 records
Pythia Biosciences partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered major, core and strategic.
- CyberomiX Inc.majorPythia Biosciences and CyberomiX Inc. announced a strategic collaboration in January 2026 aimed at supporting the rapidly growing demand for single-cell omics research in Japan. Through this partnership, CyberomiX customers receive advanced interactive analysis of single-cell data using the C-DIAM Multi-Omics Studio, supporting the full workflow from data generation to analysis.
- GeneX India BiosciencecorePythia Biosciences and GeneX India Bioscience announced a collaboration in November 2025 to bring the C-DIAM Multi-Omics Studio platform to the Indian scientific community, targeting researchers in immunology, oncology, and neuroscience. GeneX serves as the local implementation partner, providing onboarding, product introduction, and support services for academic and pharmaceutical researchers across India. The SaaS platform supports multi-omics analysis including single-cell RNA-seq, spatial transcriptomics, proteomics, and metabolomics, with access to approximately 126 million cells in the Pythiomics database.
- GMO Research Activity Support & Technology Ltd.corePythia Biosciences and GMO Research Activity Support & Technology Ltd. announced a partnership in October 2025 to bring the C-DIAM Multi-Omics Studio to scientists across Japan. GMO Research Activity Support & Technology distributes and provides comprehensive hands-on support from tool onboarding and troubleshooting to interpretation of analysis results and publication of research outcomes. Founded in 2016 and based in Tokyo within the GMO Internet Group, it has supported various single-cell analysis and spatial gene expression analysis projects for university research laboratories and corporate clients in Japan.
- TOMY Digital BiologycorePythia Biosciences and TOMY Digital Biology announced a strategic partnership in July 2025 to bring the C-DIAM Multi-Omics Studio to researchers across Japan. TOMY Digital Biology serves as the local distributor, providing local support, training, and implementation services to academic and pharmaceutical researchers. Founded in 2001 as a spin-off from TOMY Seiko (60+ years of precision laboratory equipment market leadership), TOMY Digital Biology serves as the Japanese distributor for global life science research companies. Modern analytics supported include automated cell type annotation, interactive visualizations, cross-omics integration, and customizable target prioritization.
- ROKIT GenomicscorePythia Biosciences and ROKIT Genomics announced a strategic collaboration in May 2024 for advancing single-cell sequencing data analysis in South Korea. ROKIT Genomics was appointed as the exclusive distributor of Pythia Biosciences in the South Korean market, distributing the C-DIAM Multi-Omics Studio platform licenses to the life science research community with exclusive discounted pricing during the initial year. ROKIT Genomics is a premier biomedical R&D service provider offering end-to-end single-cell sequencing services including Single Cell Gene Expression, Single Cell Immune Profiling, Single Nuclei Gene Expression, and CITE-seq.
- MiraomicsstrategicMiraomics provides a transformer-based AI solution called MiraTyper for automated cell type prediction. The Pythiomics database is expected to be robustly powered by MiraTyper in the upcoming year. Miraomics CEO Dr. Eugene Bolotin participates in Pythia Biosciences webinars discussing AI-driven cell type annotation. Dr. Ming Tang, Director of Bioinformatics at AstraZeneca, has also collaborated on joint webinars with Pythia.
Scale indicators3 records
Recent moves11 records
Expansion highlights5 records
Pythia Biosciences competitors and assessment
Company assessmentMarket position
Weaknesses5 records
Competitive moat4 records
Key highlights7 records
Customer concentration
Pythia Biosciences social profiles
Digital presencePythia Biosciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pythia Biosciences leadership team
Management profileNumber of profiles
Profiles1 record
Pythia Biosciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pythia Biosciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pythia Biosciences
What does Pythia Biosciences do?
Pythia Biosciences provides the C-DIAM Multi-Omics Studio, a cloud-based SaaS platform that enables biologists and bioinformaticians to analyze and integrate multi-omics data including single-cell RNA-seq, spatial transcriptomics (10x Visium HD, Visium, Stereo-seq, Xenium, CosMx), proteomics, metabolomics, and bulk RNA-seq through a no-code graphical user interface. The platform is complemented by the Pythiomics curated single-cell database (~126 million cells with AI-driven metadata harmonization), Pythiomics APIs for programmatic access, and Single-Cell Curation and Atlas Building Services for end-to-end dataset delivery.
Is Pythia Biosciences a public or private company?
Pythia Biosciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Pythia Biosciences founded?
Pythia Biosciences was founded in 2023. It employs 11 to 50 people.
Where is Pythia Biosciences based?
Pythia Biosciences is headquartered in Carlsbad, United States, in the North America region.
How does Pythia Biosciences make money?
Two revenue lines are on record. C-DIAM Multi-Omics Studio SaaS Platform Subscription is the primary driver. The others are single-Cell Curation and Atlas Building Services.
Does Pythia Biosciences have an API?
Yes. Pythiomics APIs provide programmatic access to Pythia's curated omics database, enabling direct querying in bioinformatics environments such as RStudio or Jupyter Notebook. The API supports data access and retrieval from the Pythiomics single-cell database. Developer documentation is at www.pythiabio.com/pythiomics-api.